Symrise (OTCMKTS:SYIEY) Cut to Hold at Zacks Research

Zacks Research downgraded shares of Symrise (OTCMKTS:SYIEYFree Report) from a strong-buy rating to a hold rating in a research note released on Monday morning,Zacks.com reports.

A number of other brokerages have also recently commented on SYIEY. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Symrise in a research note on Monday, November 24th. Baader Bank raised Symrise to a “buy” rating in a research note on Friday, August 8th. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, Symrise presently has an average rating of “Buy”.

Check Out Our Latest Report on SYIEY

Symrise Stock Performance

Symrise stock opened at $19.92 on Monday. The company has a quick ratio of 0.83, a current ratio of 1.49 and a debt-to-equity ratio of 0.34. Symrise has a 1-year low of $19.61 and a 1-year high of $30.58. The company has a fifty day simple moving average of $21.44 and a 200 day simple moving average of $24.32.

Symrise Company Profile

(Get Free Report)

Symrise AG supplies fragrances, flavorings, cosmetic active ingredients and raw materials, and functional ingredients in Europe, Africa, the Middle East, North America, the Asia Pacific, and Latin America. It operates through two segments, Taste, Nutrition & Health; and Scent & Care. The Taste, Nutrition & Health segment provides functional ingredients and product solutions used in the production of food and beverages; savory flavors; natural and sustainable ingredients for food and beverage manufacturers, baby food, and dietary supplements; product solutions and services for pet food manufacturers; sustainable ingredients and services for fish feed manufacturers to develop solutions for fish and shrimp farms; and probiotics for food supplements and functional foods.

Recommended Stories

Receive News & Ratings for Symrise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Symrise and related companies with MarketBeat.com's FREE daily email newsletter.